Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmologic… Read more
Market Cap & Net Worth: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (2TZ)
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (F:2TZ) has a market capitalization of $28.12K (€27.40K) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #6459 globally and #685 in its home market, demonstrating a 5.42% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's stock price €2.87 by its total outstanding shares 9548 (9.55K).
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Market Cap History: 2026 to 2026
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's market capitalization history from 2026 to 2026. Data shows growth from $28.12K to $28.12K (0.00% CAGR).
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 2TZ by Market Capitalization
Companies near Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited by market ranking:
- JYP Entertainment Corporation (KQ:035900): Ranked #6450 globally with a market cap of $1.25 Billion USD ( ₩1.83 Trillion KRW).
- flatexDEGIRO AG (PINK:FNNTF): Ranked #6451 globally with a market cap of $1.25 Billion USD.
- Denka Company Limited (F:DIK): Ranked #6460 globally with a market cap of $1.24 Billion USD ( €1.21 Billion EUR).
- NV5 Global Inc (NASDAQ:NVEE): Ranked #6461 globally with a market cap of $1.24 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #6450 | JYP Entertainment Corporation | KQ:035900 | $1.25 Billion | ₩66400.00 |
| #6451 | flatexDEGIRO AG | PINK:FNNTF | $1.25 Billion | $15.15 |
| #6460 | Denka Company Limited | F:DIK | $1.24 Billion | €17.70 |
| #6461 | NV5 Global Inc | NASDAQ:NVEE | $1.24 Billion | $22.56 |
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Historical Marketcap From 2026 to 2026
Between 2026 and today, Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's market cap moved from $28.12K to $ 28.12K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €28.12K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $28.12K USD |
| MoneyControl | $28.12K USD |
| MarketWatch | $28.12K USD |
| marketcap.company | $28.12K USD |
| Reuters | $28.12K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.